Viridian Therapeutics, Inc.

This study gave continued access to an experimental drug called VRDN-001 to people with thyroid eye disease who did not improve enough in previous trials. The goal was to see if longer treatment could help reduce eye bulging and double vision, and to check the drug's safety. It i…

This study tested the safety of an experimental drug called VRDN-001 for people with thyroid eye disease, a condition that causes eye inflammation and swelling. The trial involved 231 participants and was designed to see how well people tolerate the treatment and what side effect…

This study tested whether a new drug called veligrotug could safely reduce eye bulging and other symptoms in people with chronic thyroid eye disease. 188 participants received either the drug or a placebo through IV infusions over 12 weeks. Researchers measured changes in eye pro…